Evidence map›Paper›PMID 40333385›Full record

ArticleMaterials (Basel, Switzerland)2025

As-Casting Structure and Homogenization Behavior of Ta-Containing GH4151 Ni-Based Superalloy.

Tianliang Cui, Xingfei Xie, Wugang Yu, Jinglong Qu, Shaomin Lyu, Jinhui Du

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tianliang CuiChina Iron and Steel Research Institute Group Co., Ltd., Beijing 100081, China.
Xingfei XieChina Iron and Steel Research Institute Group Co., Ltd., Beijing 100081, China.
Wugang YuNCS Testing Technology Co., Ltd., Beijing 100081, China.
Jinglong QuChina Iron and Steel Research Institute Group Co., Ltd., Beijing 100081, China.
Shaomin LyuChina Iron and Steel Research Institute Group Co., Ltd., Beijing 100081, China.ORCID 0000-0003-2873-894X
Jinhui DuChina Iron and Steel Research Institute Group Co., Ltd., Beijing 100081, China.

Funding

National Natural Science Foundation of China 52074092National Natural Science Foundation of China 52274330National Science and Technology Major Project; J2019-VI-0006-0120
6 · The paper itself

Abstract

In this paper, the as-cast microstructure, microsegregation, the kinetics of secondary precipitation phase, and thermal deformation behavior in Ta-containing GH4151 alloy (Ta-GH4151) were studied using optical microscope (OM), scanning electron microscope (SEM), electron probe (EPMA), differential scanning calorimetry (DSC), mechanical testing and simulation (MTS) and electron backscattering diffraction (EBSD). The results indicate that Ti, Ta, Nb and Mo are mainly distributed in the interdendritic region and exhibit negative segregation characteristics, while Cr and W are mainly distributed in the dendritic arm region and exhibit positive segregation characteristics. The initial dissolution temperatures for Laves phase, eutectic (γ + γ') and η phase are 1140-1150 °C, 1150-1160 °C and 1170-1180 °C, respectively. The diffusion activation energies of Nb, Ta and W are 313 kJ/mol, 323 kJ/mol and 345 kJ/mol, respectively. The hot deformation activation energy of Ta-GH4151 alloy after homogenization is 1694.173 kJ/mol. Based on the constitutive equation and hot processing map, the optimum hot deformation temperature and strain rate range are determined to be 1160-1170 °C/0.3-1 s

Indexed as

activation energydiffusion coefficienthot deformationmicrostructure and microsegregationNi-based superalloy

Identifiers

PMID40333385
PMCPMC12028858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.